Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market Insights, Inc. Rising lab automation rates enabling faster and precise diagnosis in order to cater the increasing procedure volumes, and introduction of technologically advanced products should spur the global autoimmune disease diagnostics market size.
The U.S. autoimmune diagnostics market dominated North America, exceeding USD 3.5 billion by 2023. The U.S. population showcases high prevalence of autoimmune diseases, with heightened awareness levels leading to more diagnosis.
The autoimmune disease diagnostics industry is predominantly driven by the presence of favorable initiatives aimed at enhancing patient awareness, increased R&D funding, and target disease prevalence with consequent rise in number of tests.
Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/618
Various initiatives are being taken to curb the rising autoimmune disease prevalence. According to NIH Autoimmune Disease Coordinating Committee (ADCC), autoimmune diseases affect around 14 to 22 million people in the U.S. causing a significant amount of emotional, social, and financial burden to the country’s health care system. For instance, annual medical costs for treating multiple sclerosis have been estimated to be $2.5 billion, which is even higher than cost for treating diabetes. Citing this, the government has shifted its focus on curbing and treating autoimmune diseases, leading to a rise in demand for diagnostics.
The federal planning for autoimmune diseases research includes the formation of The NIH Autoimmune Diseases Coordinating Committee (ADCC), that coordinates autoimmune diseases research work of the U.S. Food and Drug Administration (FDA), Department of Veterans Affairs (VA), National Institutes of Health, the Centers for Disease, Control and Prevention (CDC), and private organizations.
Browse key industry insights spread across 82 pages with 30 market data tables & 28 figures & charts from the report, “Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents:
Key insights from the report include:
Last updated on: 14/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.